Researchers continue to excited about this new drug, a novel dual agonist showing significant results in early trials for body loss . It works by modulating both pathways : GLP-1 and GIP, these, when engaged , assist regulate cravings and enhance metabolism . Preliminary findings indicate substantial body reduction and potential benefits for indivi